TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction

0301 basic medicine QH301-705.5 Nuclear Receptor Coactivators Gene Expression Endosomes Cell Line 03 medical and health sciences Humans Protein Isoforms Viral Pseudotyping Biology (General) Immune Evasion Furin SARS-CoV-2 Serine Endopeptidases COVID-19 RC581-607 Virus Internalization 3. Good health Proteolysis Spike Glycoprotein, Coronavirus Interferons Immunologic diseases. Allergy Lysosomes Research Article
DOI: 10.1371/journal.ppat.1009820 Publication Date: 2021-11-22T18:35:05Z
ABSTRACT
Interferons play a critical role in regulating host immune responses to SARS-CoV-2, but the interferon (IFN)-stimulated gene (ISG) effectors that inhibit SARS-CoV-2 are not well characterized. The IFN-inducible short isoform of human nuclear receptor coactivator 7 (NCOA7) inhibits endocytic virus entry, interacts with the vacuolar ATPase, and promotes endo-lysosomal vesicle acidification and lysosomal protease activity. Here, we used ectopic expression and gene knockout to demonstrate that NCOA7 inhibits infection by SARS-CoV-2 as well as by lentivirus particles pseudotyped with SARS-CoV-2 Spike in lung epithelial cells. Infection with the highly pathogenic, SARS-CoV-1 and MERS-CoV, or seasonal, HCoV-229E and HCoV-NL63, coronavirus Spike-pseudotyped viruses was also inhibited by NCOA7. Importantly, either overexpression of TMPRSS2, which promotes plasma membrane fusion versus endosomal fusion of SARS-CoV-2, or removal of Spike’s polybasic furin cleavage site rendered SARS-CoV-2 less sensitive to NCOA7 restriction. Collectively, our data indicate that furin cleavage sensitizes SARS-CoV-2 Spike to the antiviral consequences of endosomal acidification by NCOA7, and suggest that the acquisition of furin cleavage may have favoured the co-option of cell surface TMPRSS proteases as a strategy to evade the suppressive effects of IFN-induced endo-lysosomal dysregulation on virus infection.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (97)
CITATIONS (22)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....